Digital Diagnostics Leader 5C Network Acquires US-based AI Platform Krayen

-       5C Network's acquisition of Krayen marks a new milestone in the company's growth: combining the power of advanced analytics and AI in digital diagnostic

-       With this acquisition, 5C Network aims to strengthen/double its digital scanning services targeting a billion scans a year by 2025

After the strategic investment by Tata 1mg and recent fundraise last year, digital diagnostic platform 5C Network acquires Krayen, Inc, a startup focused on healthcare applications and AI models to detect a variety of ailments in X-Rays and CT scans. With core expertise in statistics, analytics, AI/ML, data engineering and platform engineering, Krayen has a team size of 15 located out of India and California. The acquisition of Krayen Inc is a strategic move by 5C Network to expand its offerings in the field of digital diagnostics. By combining 5C Network's expertise in digital diagnostics with Krayen's AI and ML technologies, the newly merged company will be able to provide even more advanced and accurate diagnostic solutions to healthcare providers and patients.

Krayen was founded in 2020 by Bargava Subramanian and Kirthiraj Yuvaraj in California, U.S.. The founders have deep expertise in building, operationalizing, and scaling AI and data-driven products. Currently, Krayen serves 15 clients globally. They use computer vision and NLP to help hospitals and healthcare providers deliver superior patient outcomes. Their vertically-focused Generative AI helps hospitals provide personalized treatment plans. By analyzing patient data, such as medical history, genetics, and lifestyle factors, they recommend treatment plans tailored to each patient.

“We are excited to build on Krayen’s expertise in AI, ML, data and platform engineering. We are in a quest to build an intelligent and robust platform that can serve a billion scans a year, and Krayen’s ability to process massive amounts of data and bring out valuable insights will advance 5C’s efforts to make this a reality. ” Kalyan Sivasailam, CEO of 5C Network. He further added, “ To make diagnostics accurate, accessible and affordable, our new suite of AI products will be a massive leap in becoming the world’s first truly AI-driven diagnostics platform.”

Commenting on the merger, Bargava Subramanian, co-founder & CEO of Krayen  said, “5C Network is building the most important digital resources in India today. As a team, we have faced the challenge and impact of delayed, incorrect and inactionable diagnosis, and we believe that our deep expertise in AI, ML, Deep Learning and data engineering is an essential piece of the puzzle when solving for better diagnostics. We resonate with 5C’s vision and mission, and the team at Krayen is more motivated than ever to drive towards this goal.”

Medical diagnostics is a USD 11Bn market in India growing at a rate of 16% y-o-y. While pathology has been centralized and scaled, radiology is still lagging behind when about 85% of moderate to severe illness needs radiology intervention. 5C Network has been making strides to shift the whole diagnostic experience for patients - from booking a test to obtaining accurate and timely reports digitally, with an average TAT of 39 minutes and an accuracy of over 99.3%, across India.

5C Network is able to do this through a collaborative network of radiologists powered by their Prodigi platform - an intelligent platform that can integrate multiple AIs seamlessly. While AI companies must focus for years on one ailment, prodigi gives them a platform to transact on through deep integrations. Prodigi.ai has enabled over 2000 hospitals and diagnostics centers in 300 cities to deliver accurate, fast, actionable diagnosis and reports to patients and referring physicians.

About 5C Network

5C Network is building digital infrastructure for delivering better healthcare diagnostics in India. The company provides marketplace-like access for diagnostic establishments, radiologists and patient aggregation and management providers. Through its cutting-edge Prodigi (www.prodigi.ai) platform, 5C delivers 1.5 radiological reports annually to 2000 hospitals and diagnostic centers across 300 cities in India. The company has successfully raised Series A capital from marquee global and strategic investors.

HMI To Induce Thrilling Experiences On Hyundai ALCAZAR With New 1.5 Turbo GDi Petrol Engine

*‘Bookings Open’

* As part of Model Year 2023 (MY’23) introductions, Hyundai ALCAZAR will now feature a new 1.5 Turbo GDi Petrol Engine for thrilling and sporty driving experiences

*   The new 1.5 T-GDi Petrol Engine is RDE compliant and E20 fuel ready and will be offered with two transmission options – 7DCT and 6MT

*   New powertrain offers best-in-segment fuel efficiency and strong turbo petrol performance with Max. Power of 117.5 kW (160 PS) & Max. Torque of 253 Nm

*   Additionally, as part of MY’23 updates, Hyundai ALCAZAR will now boast of a new front grille design and puddle lamp logo.

*   Hyundai ALCAZAR will now also feature ISG (Idle Stop & Go) as well as Side Airbag & Curtain Airbag as stock fitment across trims, thus offering a total of 6-Airbags as standard

*  Hyundai ALCAZAR will continue to be available with RDE compliant 1.5 l diesel CRDi engine that produces 85 kW (116 PS) / 4 000 r/min and 250 Nm / 1 500 – 2 750 r/min

Hyundai Motor India Limited (HMIL), India’s first smart mobility solutions provider and largest exporter since inception, today opened bookings for Hyundai ALCAZAR powered by a new 1.5 Turbo GDi Petrol engine that is RDE compliant and also E20 fuel ready. Offering a thrilling driving experience, Hyundai ACLAZAR can now be booked by clicking on (https://clicktobuy.hyundai.co.in/#/bookACar?modelCode=AA) or across Signature Outlets in India for Rs. 25 000.

Speaking on the announcement, Mr. Tarun Garg, Chief Operating Officer, Hyundai Motor India Ltd., said, “As we continue to redefine customer experiences across our model range, we are glad to introduce Hyundai ALCAZAR with a benchmark defining new turbo petrol engine that will meet aspirations of our most loved customers. Additionally, we have refined the design of Hyundai ALCAZAR as well as introduced new technologies to amplify Grand Experiences with this new age mobility solution. Hyundai ALCAZAR has been a steadfast volume driver for HMI and these new updates will certainly drive more affinity towards the brand. Further, we are well aligned with the Government’s mission of cleaner mobility solutions and the new 1.5 Turbo GDi petrol powertrain will be both RDE compliant and E20 fuel ready.”

The new 1.5 Turbo GDi petrol engine of Hyundai ALCAZAR is paired with two transmission options – 7DCT and 6MT. The new powertrain is set to offer customers a thrilling driving experience with Max. Power of 117.5 kW (160 PS) / 5 500 r/min and Max. Torque of 253 Nm / 1 500 ~ 3 500 r/min. While offering strong performance, the new 1.5 Turbo GDi is also the segment’s most fuel efficient powertrain with the 7DCT version offering a top mileage of 18 km/l and the 6MT returning 17.5 km/l.  Hyundai ALCAZAR will continue to be available with this segment’s most fuel efficient and RDE compliant 1.5 l diesel CRDi engine that produces 85 kW (116 PS) / 4 000 r/min and 250 Nm / 1 500 – 2 750 r/min.

In addition, Hyundai ALCAZAR will feature design changes with a new front grille design that enhances the aesthetics of this 6 & 7 Seater SUV, giving it a bold and masculine new look. Hyundai has also upgraded the puddle lamp logo that now features the ‘ALCAZAR’ emblem. As part of the MY’23 updates, Hyundai ALCAZAR will now be offered to customers with 6-Airbags as standard (Driver, Passenger, Side & Curtain), while also introducing Idle Stop & Go feature as stock fitment, thereby enhancing the convenience quotient of this SUV.

About HMIL

Hyundai Motor India Limited (HMIL) is a wholly-owned subsidiary of Hyundai Motor Company (HMC). HMIL is India’s first smart mobility solutions provider and the number one car exporter since its inception in India. It currently has 12 car models across segments GRAND i10 NIOS, All New i20, i20 N Line, AURA, VENUE, VENUE N Line, Spirited New VERNA, All New CRETA, ALCAZAR, New TUCSON, KONA Electric and All Electric SUV IONIQ 5. HMIL’s fully integrated state-of-the-art manufacturing plant near Chennai boasts advanced production, quality, and testing capabilities.

HMIL forms a critical part of HMC’s global export hub. It currently exports to around 85 countries across Africa, the Middle East, Latin America, Australia, and Asia Pacific. To support its growth and expansion plans, HMIL currently has 583 dealers and more than 1492 service points across India. In its commitment to providing customers with cutting-edge global technology, Hyundai has a modern multi-million-dollar R&D facility in Hyderabad. The R&D centre’s endeavour is to be a centre of excellence in automobile engineering.

Airtel Surpasses 10 Million Unique Customers On Its 5G Network

Bharti Airtel (“Airtel”), India’s leading telecommunications services provider today announced that it has crossed the 10 million unique 5G user mark on its network. Airtel was the first service provider to roll-out 5G services in the country in October 2022. Today, Airtel 5G Plus is available across all states in the country. The company is well poised to cover every town and key rural areas with Airtel 5G services by end of March 2024. In November 2022, Airtel became the first and only operator to have 1 million unique customers on its network within 30 days of its commercial launch.

Randeep Sekhon, CTO, Bharti Airtel, said “These are early days, but we are thrilled with the response we have received from our customers. Airtel will continue to stay true to its commitment to build a more connected, equitable and sustainable network. With cutting edge 5G infrastructure, a fantastic partner ecosystem and a dedicated workforce that is customer obsessed, we believe we are in the right path to win and deliver a world-class 5G Plus experience to customers across the length and breadth of the country.”

Airtel 5G Plus has three compelling advantages for customers. First, it runs on a technology that has the widest acceptance in the world with the most developed ecosystem. This ensures that all 5G smartphones in India seamlessly work on the Airtel network. Second, the company promises to deliver the best experience – between 20 to 30 times higher speeds than today coupled with brilliant voice experience and super-fast call connect. Finally, Airtel 5G Plus network will also be kinder to the environment with its special power reduction solution.

In the last one year, Airtel has demonstrated the power of 5G with a host of powerful use cases that will change the way customers lead their lives and do business. From India’s first live 5G network in Hyderabad to India's first private 5G network at the BOSCH facility in Bengaluru to partnering with Mahindra & Mahindra to make its Chakan manufacturing facility, India’s first 5G enabled auto manufacturing unit, Airtel has been at the forefront of 5G innovation. 

Airtel has created 5G experience zones across all its retail stores in the country. Customers can walk-in to any store to experience ultrafast Airtel 5G Plus. To know more about Airtel 5G Plus please log on to https://www.airtel.in/5g-network

About Bharti Airtel Limited

Headquartered in India, Airtel is a global communications solutions provider with over 500 Mn customers in 17 countries across South Asia and Africa. The company ranks amongst the top three mobile operators globally and its networks cover over two billion people. Airtel is India’s largest integrated communications solutions provider and the second largest mobile operator in Africa. Airtel’s retail portfolio includes high speed 4G/5G mobile broadband, Airtel Xstream Fiber that promises speeds up to 1 Gbps with convergence across linear and on-demand entertainment, streaming services spanning music and video, digital payments and financial services. For enterprise customers, Airtel offers a gamut of solutions that includes secure connectivity, cloud and data centre services, cyber security, IoT, Ad Tech and CPaaS (Airtel IQ). For more details visit www.airtel.com

Nestlé MUNCH's #CRUNCHYOURATTITUDE Campaign Encourages Teens To Express Themselves With Confidence

In today’s time, when teens are all about expressing themselves, Nestlé MUNCH launches its #CRUNCHYOURATTITUDE campaign that encourages them to express themselves more confidently.

Nestlé MUNCH has created quirky packs that celebrates different passion points such as sports, gaming, fashion and social media that gives teens a chance to win merchandise and become stars of their chosen passion. Adding a little crunch to the lucky winners' life, MUNCH will give them an opportunity to further select their reward from the chosen passion point.

Commenting on the new campaign, Rupali Rattan, Head - Confectionery Business, Nestlé India said, “Today's teenagers are full of dreams and aspirations. They leave no stone unturned to achieve anything they set their minds to. Enabling the teenagers to shine and follow their ambition, Nestlé MUNCH's new campaign #CRUNCHYOURATTITUDE enables them to not only confidently express themselves but also pursue their passion.”

Toyota Innova HyCross Wins ‘MPV Of The Year’ At Autocar Awards 2023

All New Innova HyCross has been awarded the 'MPV of the Year' at the Autocar Awards 2023 recently held in Mumbai. Uniquely designed to meet the diverse needs of Indian families, the feature laden and versatile All New Innova HyCross is a vehicle for every occasion delivering powerful performance, glamour, toughness, comfort, safety, and advanced technology. This along with its Self-charging Strong Hybrid Electric and gasoline variants make the All New Innova HyCross perfectly poised to meet the varied aspirations of Indian customers.

Commenting on the accolade, Mr. Atul Sood, Vice President, Sales and Strategic Marketing, Toyota Kirloskar Motor said, "We are honored and elated to receive the ‘MPV of the Year’ award for the All New Innova HyCross. We are humbled by the overwhelming response and admiration that the All New Innova HyCross has received, just months after its launch in the Indian market. We are proud to offer our customers a vehicle that meets their mobility needs as well as provides them with a sense of luxury and comfort as the All New Innova HyCross checks all the boxes.”

All New Innova HyCross is powered by  5th Generation Self-Charging Strong Hybrid Electric System with TNGA 2.0 Litre 4-cylinder gasoline engine on a monocoque frame with an e-drive sequential shift delivering a max power output of 137 kW (183.7 HP), providing rapid acceleration and best in segment fuel economy of 23.24 kmpl^. The vehicle also comes with the option of a TNGA 2.0 Litre 4-cylinder gasoline engine mated to a direct shift CVT in select grades delivering an output of 129 kW (171.6 HP) and offering class leading fuel economy of 16.13 kmpl^.

All New Innova Hycross is also loaded with several first in segment features including Paddle shift, Powered Ottoman 2nd row seats, Front Ventilated seats, Air conditioner (Dual zone – front and rear zone), Rear Retractable Sunshade, Electrochromic Inner Rear View Mirror (EC IRVM), Power  Back Door, Dual Function, Daytime Running Light (DRL) and also the TOYOTA SAFETY SENSETM (TSS)** which is introduced first time in India for Toyota vehicles to further enhance safety and provide peace of mind to all customers.

Available in Super White, Platinum White Pearl, Silver Metallic, Attitude Black Mica, Sparkling Black Pearl Crystal Shine, Avant Grade Bronze Metallic and an exciting new color Blackish Ageha Glass Flake, interiors of the All New Innova HyCross come in Black with two new colors - Chestnut with Black and Dark Chestnut, giving an advanced and premium impression.

All New Innova HyCross offers the renowned Toyota experience through a warranty of 3 years/100,000 kilometers and an option of extended warranty of up to 5 years/220,000 kilometers, 3 years free roadside assistance, attractive financial schemes and 8 yrs/160,000 kilometers warranty on the Hybrid battery.

The Innova has been a highly successful model for TKM in India since its launch in 2005. Innova has been a popular choice for customers in the MPV segment, thanks to its spacious and comfortable cabin, reliable performance, and Toyota's renowned safety standards.

ACC Develops High-Quality Temperature-Controlled Concrete, Coolcrete

* Reduces heat of hydration, minimises thermal cracking

ACC Limited, the cement and building materials company of Adani Cement and part of the Adani Group, has formulated a temperature–controlled concrete, ‘Coolcrete’. It has been developed to prevent the rise of the internal temperature of the concrete beyond the specified limits for mass concreting or large pours. It reduces the heat of hydration, minimising the risk of thermal cracking and delayed ettringite formation in mass concrete.

The Peerless Hospital in Kolkata is upgrading its existing medical infrastructure with ‘Coolcrete’. The hospital is building a new block between outpatient and oncology departments for confined cancer treatment by erecting a 1600mm radiation wall using M30 grade RMC at 25°C and a slump of 150 mm-160 mm.

The product has a strength of up to M100 with 550-750mm flow and high segregation resistance. It also ensures the reduction of drying shrinkage and concrete bleeding. Structures built with ‘Coolcrete’ are more durable than conventional concrete structures due to fewer internal cracks and better resistance to water and chloride ingress.

Mr. Ajay Kapur, CEO, Cement Business said, “Our innovative products are developed keeping in my mind the unique needs of our customers. ‘Coolcrete’ and several of our other products are outcome of our best practices and expertise in this domain. We keep innovation at the core of our business and are also mindful of the quality offered, which is beyond comparison. We have always strived to produce superior quality products for our customers to cater to their varied requirements and help them build sustainable structures.”

Adani Cement is committed to building nations with goodness and is making unremitting efforts to become the most innovative, sustainable, and economical cement and building solutions company in India.

Venus Remedies Awarded Saudi GMP Approval For All Its Production Facilities In Baddi

*  The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region as well as other countries in GCC and MENA regions which consider SFDA as reference authority

* Venus Remedies has received three additional facility approvals and successfully renewed four existing facility approvals from SFDA, opening up a massive market for its existing and upcoming product portfolio

In an important endorsement of its world-class manufacturing standards, Venus Remedies Ltd, one of India’s leading research-based pharmaceutical companies, has received good manufacturing practices (GMP) certification from Saudi Arabia for all its production facilities at its unit in Baddi, Himachal Pradesh. With this, the number of international GMP certifications for Venus Remedies has gone up to 20.

While the Saudi Arabian market happens to be the largest in the Gulf Cooperation Council (GCC) region, this GMP approval is also expected to soon pave the way for marketing authorisations from other countries in GCC and Middle East and North Africa (MENA) regions which consider the Saudi Food and Drug Authority (SFDA) as reference authority. Saudi Arabia also happens to be the leading country in the entire Gulf region in terms of quality benchmarks.

The SFDA granted the certification, which included first-time approval for pre-filled Enoxaparin syringes and general injection facilities, and renewed approval for Cephalosporin and Carbapenem antibiotics and liquid and lyophilised oncology drugs, after an extensive review and audit of the company’s facilities. Among the world’s top 10 fixed-dosage injectable manufacturers, Venus Remedies has a fully automated robotic PFS (Prefilled Syringe) machine that ensures optimum quality.

In terms of products, this GMP certification for three more facilities applies to small-volume injectables, dry-powder vials, liquid vials and ampoules, and lyophilised vials.

Hailing the company’s achievement as an opportunity to penetrate faster in the entire Gulf region, Akshansh Chaudhary, Executive Director, Venus Remedies, said, “This accreditation is a major milestone for us and will help us further expand our operations, reach new markets and strengthen our reputation as a trusted provider of high-quality pharmaceutical products. We remain committed to making a positive impact on global health and will continue to invest in our facilities and processes to ensure that we can provide the best possible care to patients worldwide.”

Venus Remedies is well-positioned to build a high-value portfolio of soon-to-be off-patent products in the GCC region as a result of these additional approvals.

Speaking on the development, Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre, said, “We are already market leaders for our key antibiotic products in Saudi Arabia, where we have nine marketing authorisations. With the additional renewals, we are looking to expand massively in the GCC and MENA regions.”

Planning to consolidate its position in Saudi Arabia and other GCC countries through product registrations and common technical dossiers (CTDs), Venus Remedies has already filed a CTD in Saudi Arabia for Enoxaparin, for which marketing approval is expected shortly. The company is also awaiting marketing authorisation from Saudi Arabia for another six-seven oncology products anytime soon.

Since 2014, Venus Remedies has sold more than 12 million units of drugs in the $7.8-billion Saudi Arabian pharmaceutical market (as of 2021), which is expected to grow to $13.1 billion by 2031 at a 10-year CAGR of 5.4 per cent. The company’s registered products in Saudi Arabia include six antibiotics meant for intensive care units (ICUs) and three oncology products.

About Venus Remedies

Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 60+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. Its manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS. The company has also been approved by European-GMP, WHO-GMP and Latin American GMP (INVIMA), among others. Ranked 107th in Asia and among the world’s 500 largest pharmaceutical manufacturing companies, Venus Remedies has won more than 100 patents, 70 trademarks and 12 copyrights for its innovative research products worldwide.